Pharmaceutical Manufacturing Market Size, Share, Analysis Report

Pharmaceutical Manufacturing Market Size By Drug Development Type (Outsource, In-house), By Formulation Outlook (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations), By Route of Administration Outlook (Oral, Topical, Parenteral, Inhalations, Other Routes of Administration), By Therapy Area Outlook (Cardiovascular Diseases, Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases), By Prescription Outlook (Prescription Medicines, Over-the-counter (OTC) Medicines), By Age Group Outlook (Children & Adolescents, Adults, Geriatric), By Distribution Channels Outlook (Retail, Non-retail), By Region (North America, Europe, Asia Pacific, Rest of the World) Market Analysis Report, Global Forecast

Pharmaceutical Manufacturing Market is projected to grow up to US$ 950 billion by 2028 growing at a CAGR of 13.74%during the forecasting period 2023-2028.

Purchase User License

MARKET SNAPSHOT

Major Players

  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • GlaxoSmithKline plc
  • Pfizer, Inc
  • AstraZeneca
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    13

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    The pharmaceutical business is a dynamic part of the larger healthcare ecosystem. The pharmaceutical industry mainly deals with the development of medications and scientific research activities that avert or treat ailments and disorders. Pharmaceutical manufacturing is the process of commercial-scale creation of medicines by pharmaceutical establishments. The rising demand for modernization of pharmaceutical manufacturing procedure has prompted leading companies to employ new technologies such as continuous pharmaceutical manufacturing. This technology offers superiority, probable flexibility, and economic rewards over batch processing, together in process manufacturing and development for the pharmaceutical sector. Features such as rising geriatric population, growing prevalence of chronic ailments, high investment in research and development, increasing focus on outsourcing manufacturing activities, increasing per capita healthcare expenditure, rising incidence of novel viral diseases, technological advancements in manufacturing processes, and improving reimbursement scenario in developing regions are driving the development of pharmaceutical manufacturing market. Improved focus on elderly and pediatric patients, growing demand for home-based healthcare, high incidence of cardiovascular disorders, and increased cancer and diabetes cases are further propelling the pharmaceutical manufacturing market expansion across the globe.

    Pharmaceutical Manufacturing Market is projected to grow up to US$ 950 billion by 2028 growing at a CAGR of 13.74%during the forecasting period 2023-2028.

    Report Scope

    The global market report scope consists of a comprehensive study covering primary factors impacting the industry trends. The study includes analysis of regional and country-level market dynamics. The scope also consists of competitive overview offering company market shares coupled with company profiles for key revenue contributing companies. The report scope covers a detailed competitive outlook covering market shares and profiles of key participants in the market share.

    Major Market Players

    The key players of the market are F. Hoffmann-La Roche Ltd., Novartis AG, GlaxoSmithKline plc, Pfizer, Inc., AstraZeneca, Merck & Co., Inc., Johnson & Johnson, Sanofi SA, Eli Lilly and Company and Lonza.

    The Pharmaceutical ManufacturingMarket report has been categorized as below     

    By Drug Development Type

    • Outsource
    • In-house

    By Formulation Outlook

    • Tablets
    • Capsules
    • Injectable
    • Sprays
    • Suspensions
    • Powders
    • Other Formulations

    By Route of Administration Outlook

    • Oral
    • Topical
    • Parenteral
    • Inhalations
    • Other Routes of Administration

    By Therapy Area Outlook

    • Cardiovascular Diseases
    • Pain
    • Diabetes
    • Cancer
    • Respiratory Diseases
    • Other Diseases

    By Prescription Outlook

    • Prescription Medicines
    • Over-the-counter (OTC) Medicines

    By Age Group Outlook

    • Children & Adolescents
    • Adults
    • Geriatric

    By Distribution Channels Outlook

    • Retail
    • Non-retail

    By Region

    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

    The years considered for the study are as follows:

    • Base year – 2022
    • Estimated year – 2023
    • Projected year – 2022
    • Forecast period – 2023 to 2028

    Key Questions Addressed by the Report

    • New products/service competitors are exploring?
    • Key players in the Pharmaceutical Manufacturingmarket and how extreme is the competition?
    • What are the futuremarket trends that manufacturers are emphasizing on in the future updates?
    • For each segment, what are the crucial opportunities in the market?
    • What are the key growth strategies embraced by key market players in the market?
    • What are the key success strategies adopted by major competitors in the market?

    Why Buy this Report:

    • Obtain comprehensive insights on the Pharmaceutical Manufacturing& market trends
    • Note comprehensive analysis of the market status
    • Identifies the market opportunities and growth segments
    • Assessing business segments & product portfolios, and explain competitive dynamics
    • Provide strategy planning and industry dynamics to strengthen decision making

    Size, Share, Analysis Report

    Below are our New Reports :-

    Liothyronine Market

    curcumin market

    Intravenous (IV) Therapy and Vein Access Market

    India Sports Medicine Market

    human milk fortifier market

    1.    Pharmaceutical ManufacturingMarket Introduction
    1.1.    Key Insights
    1.2.    Report Overview
    1.3.    Markets Covered
    1.4.    Stakeholders
    2.    Research Methodology
    2.1.    Research Scope
    2.2.    Market Research Process
    2.3.    Research Data Analysis
    2.4.    Market Size Estimation
    3.    Executive Summary

    4.    Market Overview
    4.1.    Introduction 
    4.2.    Market Drivers and Restraints
    5.    By Drug Development Type
    5.1.    Key Points
    5.2.    Outsource
    5.3.    In-house
    6.    By Formulation Outlook
    6.1.    Key Points
    6.2.    Tablets
    6.3.    Capsules
    6.4.    Injectable
    6.5.    Sprays
    6.6.    Suspensions
    6.7.    Powders
    6.8.    Other Formulations
    7.    By Route of Administration Outlook
    7.1.    Key Points
    7.2.    Oral
    7.3.    Topical
    7.4.    Parenteral
    7.5.    Inhalations
    7.6.    Other Routes of Administration
    8.    By Therapy Area Outlook
    8.1.    Key Points
    8.2.    Cardiovascular Diseases
    8.3.    Pain
    8.4.    Diabetes
    8.5.    Cancer
    8.6.    Respiratory Diseases
    8.7.    Other Diseases
    9.    By Prescription Outlook
    9.1.    Key Points
    9.2.    Prescription Medicines
    9.3.    Over-the-counter (OTC) Medicines
    10.    By Age Group Outlook
    10.1.    Key Points
    10.2.    Children & Adolescents
    10.3.    Adults
    10.4.    Geriatric
    11.    By Distribution Channels Outlook
    11.1.    Key Points
    11.2.    Retail
    11.3.    Non-retail
    12.    By Region
    12.1.    Key Points
    12.2.    North America
    12.3.    Europe
    12.4.    Asia Pacific
    12.5.    Rest of the World
    13.    Company Profile
    (Profile contain company overview, products/services, financials & recent developments)
    13.1.    F. Hoffmann-La Roche Ltd.
    13.2.    Novartis AG
    13.3.    GlaxoSmithKline plc
    13.4.    Pfizer, Inc.
    13.5.    AstraZeneca
    13.6.    Merck & Co., Inc.
    13.7.    Johnson & Johnson
    13.8.    Sanofi SA
    13.9.    Eli Lilly and Company
    13.10.    Lonza
     

    The Pharmaceutical ManufacturingMarket report has been categorized as below     

    By Drug Development Type

    • Outsource
    • In-house

    By Formulation Outlook

    • Tablets
    • Capsules
    • Injectable
    • Sprays
    • Suspensions
    • Powders
    • Other Formulations

    By Route of Administration Outlook

    • Oral
    • Topical
    • Parenteral
    • Inhalations
    • Other Routes of Administration

    By Therapy Area Outlook

    • Cardiovascular Diseases
    • Pain
    • Diabetes
    • Cancer
    • Respiratory Diseases
    • Other Diseases

    By Prescription Outlook

    • Prescription Medicines
    • Over-the-counter (OTC) Medicines

    By Age Group Outlook

    • Children & Adolescents
    • Adults
    • Geriatric

    By Distribution Channels Outlook

    • Retail
    • Non-retail

    By Region

    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

    Got a question? We've got answers. If you have some other questions, see our support center.

    The market is expected to grow at a CAGR of 13.74% during the study period (2023-2028)
    Pharmaceutical Manufacturing Market is projected to grow up to US$ 950 billion by 2028
    The segment included in the Pharmaceutical Manufacturing Market Drug Development Type, Formulation Outlook, Route of Administration Outlook, Therapy Area Outlook Prescription Outlook, Age Group Outlook, Distribution Channels Outlook and Region.
    Some key players operating in the Pharmaceutical Manufacturing Market include F. Hoffmann-La Roche Ltd., Novartis AG, GlaxoSmithKline plc, Pfizer, Inc., AstraZeneca, Merck & Co., Inc
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports